Coronavirus-nephropathy; renal involvement in COVID-19

Rohollah Valizadeh ¹ * , Azar Baradaran ² , Azin Mirzazadeh ^3,4 , Lakkakula VKS Bhaskar ⁵

Cited by CrossRef: 33

1- El-Kassas M, Alboraie M, Elbadry M, El Sheemy R, Abdellah M, Afify S, Madkour A, Zaghloul M, Awad A, Wifi M, Al Balakosy A, Eltabbakh M. Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection. World J Clin Cases. 2023;11(3):493 [Crossref]

2- Verma H, Merchant N, Verma M, Kuru C, Singh A, Ulucan F, Verma P, Bhattacharya A, Bhaskar L. Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19). Biomedical Journal. 2020;43(5):424 [Crossref]

3- Bhaskar L, Roshan B, Nasri H. The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function. Am J Nephrol. 2020;51(7):572 [Crossref]

4- Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi M. Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection. Jundishapur J Microbiol. 2020;13(4) [Crossref]

5- Nalugo M, Schulte L, Masood M, Zayed M. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med. 2021;8 [Crossref]

6- Saberi-Movahed F, Mohammadifard M, Mehrpooya A, Rezaei-Ravari M, Berahmand K, Rostami M, Karami S, Najafzadeh M, Hajinezhad D, Jamshidi M, Abedi F, Mohammadifard M, Farbod E, Safavi F, Dorvash M, Mottaghi-Dastjerdi N, Vahedi S, Eftekhari M, Saberi-Movahed F, Alinejad-Rokny H, Band S, Tavassoly I. Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods. Computers in Biology and Medicine. 2022;146:105426 [Crossref]

7- Алексєєва В. СУЧАСНІ ПІДХОДИ ДО ЗАМІСНОЇ НИРКОВОЇ ТЕРАПІЇ COVID-АСОЦІЙОВАНИХ НЕФРОПАТІЙ. APN. 2023;(30-31):37 [Crossref]

8- Saggam A, Limgaokar K, Borse S, Chavan-Gautam P, Dixit S, Tillu G, Patwardhan B. Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management. Front Pharmacol. 2021;12 [Crossref]

9- Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, Menzel A, Dadar M, Bjørklund G. Interrelations between COVID-19 and other disorders. Clinical Immunology. 2021;224:108651 [Crossref]

10- Duksal F, Burnik C, Mermer M, Yavuz S. Evaluation of the Effect of Biochemistry Parameters on the Clinical Course in COVID-19 Patients Who Received Tocilizumab Treatment. 2022;115(7):435 [Crossref]

11- Nava-Santana , Rodríguez-Armida M. Afección extrapulmonar en COVID-19. ¿Estamos ante la nueva y enésima gran imitadora?. 2020;9(S2):167 [Crossref]

12- Verma H, Farran B, Bhaskar L. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. 2020;3(2):115 [Crossref]

13- Condon B, Whish-Wilson T, Davis N, Lawrentschuk N. In Reply: an Example of the Evolution of Evidence in a New Disease. Future Oncol. 2020;16(35):2903 [Crossref]

14- Maghool F, Valiani A, Safari T, Emami M, Mohammadzadeh S. Gastrointestinal and renal complications in SARS‐CoV‐2‐infected patients: Role of immune system. Scand J Immunol. 2021;93(4) [Crossref]

15- Matos J, Gomes E, Formiga N, Nascimento M, Lima G, Moreira T. Interventions related to cardiovascular complications in people hospitalized by covid-19: a scoping review. Rev Bras Enferm. 2021;74( suppl 1) [Crossref]

16- Maddah R, Goodarzi V, Asadi-Yousefabad S, Abbasluo M, Shariati P, Shafiei Kafraj A. Evaluation of the gut microbiome associated with COVID-19. Informatics in Medicine Unlocked. 2023;38:101239 [Crossref]

17- Nokhodian Z, Ranjbar M, Nasri P, Kassaian N, Shoaei P, Vakili B, Rostami S, Ahangarzadeh S, Alibakhshi A, Yarian F, Javanmard S, Ataei B. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment. J Res Med Sci. 2020;25(1):101 [Crossref]

18- Taghizadieh A, Mikaeili H, Ahmadi M, Valizadeh H. Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran. Respiratory Medicine Case Reports. 2020;30:101090 [Crossref]

19- Kumar P, Sobhanan J, Takano Y, Biju V. Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience. NPG Asia Mater. 2021;13(1) [Crossref]

20- Ma Y, Zhang P, Hou M. Association of hypernatremia with mortality in patients with COVID‐19: A systematic review and meta‐analysis. Immunity Inflam & Disease. 2023;11(12) [Crossref]

21- Pourfridoni M, Abbasnia S, Shafaei F, Razaviyan J, Heidari-Soureshjani R, Cavalcanti Rolla V. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications. BioMed Research International. 2021;2021:1 [Crossref]

22- Abdelsalam M, Abd El Wahab A, Nassar M, Samaan E, Eldeep A, Abdalbary M, Tawfik M, Saleh M, Shemies R, Sabry A. Kidneys in SARS‐CoV‐2 era: A challenge of multiple faces. Ther Apher Dial. 2022;26(3):552 [Crossref]

23- Mondal R, Lahiri D, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria S, Thakurta T, Singla P, Biswas S. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?. J Thromb Thrombolysis. 2020;50(3):567 [Crossref]

24- Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary Clinical Manifestations in COVID-19 Patients. 2020;103(5):1783 [Crossref]

25- Yannic K, Wolfgang H, Germar-Michael P. Cave Canem : Urine is Not Urine in Corona Times . Future Oncol. 2020;16(35):2899 [Crossref]

26- Gharebaghi N, Farshid S, Boroofeh B, Nejadrahim R, Mousavi J, Dindarian S, Mohammadi S. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. Int J Clinical Practice. 2021;75(6) [Crossref]

27- Khamidullina Z, Avzaletdinova D, Gareeva D, Morugova T, Lakman I, Kopp K, Fiedler L, Motloch L, Zagidullin N. Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients. Biomedicines. 2024;12(2):467 [Crossref]

28- Ratre Y, Kahar N, Bhaskar L, Bhattacharya A, Verma H. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech. 2021;11(2) [Crossref]

29- Verma H. Radiological and clinical spectrum of COVID-19: A major concern for public health. WJR. 2021;13(3):53 [Crossref]

30- Sahu T, Mehta A, Ratre Y, Jaiswal A, Vishvakarma N, Subrahmanya Bhaskar L, Verma H. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. WJG. 2021;27(6):449 [Crossref]

31- Malviya A, Ahirwar A, Chandra Tripathi S, Asia P, Gopal N, Kaim K. COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in Bhopal Gas Tragedy survivor. 2021;42(1):63 [Crossref]

32- Chen S, Ng C, Huang Y, Lo H. Analyzing prognosis and comparing predictive scoring systems for mortality of COVID-19 patients with liver cirrhosis: a multicenter retrospective study. BMC Infect Dis. 2024;24(1) [Crossref]